Novo Nordisk boasts 45 million customers using their drug Ozempic, which has caused a revolution in weight-loss treatment.

A Manhattan federal jury on Monday ruled in favor of Denmark's tax authority, in the first U.S. civil trial concerning the country's effort to recoup about $2.1 billion of tax refunds it claims were ...